Current Environmental Health Reports

, Volume 5, Issue 1, pp 134–144 | Cite as

Long-Term Health Effects and Underlying Biological Mechanisms of Developmental Exposure to Arsenic

  • Lisa Smeester
  • Rebecca C. Fry
Mechanisms of Toxicity (CJ Mattingly and A Planchart, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Mechanisms of Toxicity

Abstract

Purpose of Review

Exposure to inorganic arsenic (iAs) via drinking water represents a significant global public health threat with chronic exposure associated with cancer, skin lesions, neurological impairment, and cardiovascular diseases. Particularly susceptible populations include the developing fetus and young children. This review summarizes some of the critical studies of the long-term health effects and underlying biological mechanisms related to developmental exposure to arsenic. It also highlights the complex factors, such as the sex of the exposed individual, that contribute to susceptibility to the later life health effects of iAs.

Recent Findings

Studies in animal models, as well as human population-based studies, have established that prenatal and early life iAs exposures are associated with long-term effects, and many of these effects display sexually dimorphic responses. As an underlying molecular basis, recent epidemiologic and toxicologic studies have demonstrated that changes to the epigenome may play a key mechanistic role underlying many of the iAs-associated health outcomes.

Summary

Developmental exposure to iAs results in early and later life health effects. Mechanisms underlying these outcomes are likely complex, and include disrupted key biological pathways with ties to the epigenome. This highlights the importance of continued research, particularly in animal models, to elucidate the important underpinnings (e.g., timing of exposure, metabolism, dose) of these complex health outcomes and to identify the biological mechanisms underlying sexual dimorphism in iAs-associated diseases. Future research should investigate preventative strategies for the protection from the detrimental health endpoints associated with early life exposure to iAs. Such strategies could include potential interventions focused on dietary supplementation for example the adoption of a folate-rich diet.

Keywords

Arsenic exposure Epigenetics Sexual dimorphism In utero Early life 

Notes

Acknowledgements

This work was supported by grants from the National Institute of Environmental Health Sciences (R01ES019315 and P42ES005948). We would like to thank Caroline Brock Reed for her assistance with Fig. 1.

Compliance with Ethical Standards

Conflict of Interest

Lisa Smeester and Rebecca C. Fry declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Guidelines for Drinking-Water Quality, Fourth Edition. World Health Organization, 2011. http://apps.who.int/iris/bitstream/10665/44584/1/9789241548151_eng.pdf. Accessed 3 Aug 2017.
  2. 2.
    Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect. 2013;121(3):295–302.  https://doi.org/10.1289/ehp.1205875. PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Sanders AP, Messier KP, Shehee M, Rudo K, Serre ML, Fry RC. Arsenic in North Carolina: public health implications. Environ Int. 2012;38(1):10–6.  https://doi.org/10.1016/j.envint.2011.08.005.PubMedCrossRefGoogle Scholar
  4. 4.
    Baris D, Waddell R, Beane Freeman LE, Schwenn M, Colt JS, Ayotte JD, Ward MH, Nuckols J, Schned A, Jackson B, Clerkin C, Rothman N, Moore le, Taylor A, Robinson G, Hosain GMM, Armenti KR, McCoy R, Samanic C, Hoover RN, Fraumeni JF, Johnson A, Karagas MR, Silverman DT Elevated bladder cancer in northern New England: the role of drinking water and arsenic. J Natl Cancer Inst 2016;108(9).  https://doi.org/10.1093/jnci/djw099.
  5. 5.
    Steinmaus C, Yuan Y, Bates MN, Smith AH. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol. 2003;158(12):1193–201.  https://doi.org/10.1093/aje/kwg281.PubMedCrossRefGoogle Scholar
  6. 6.
    Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998;44(2):185–90.  https://doi.org/10.1006/toxs.1998.2486.PubMedCrossRefGoogle Scholar
  7. 7.
    Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009;29(1):381–99.  https://doi.org/10.1146/annurev-nutr-080508-141102.PubMedCrossRefGoogle Scholar
  8. 8.
    Vahter M. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol. 2008;102(2):204–11.  https://doi.org/10.1111/j.1742-7843.2007.00168.x.PubMedCrossRefGoogle Scholar
  9. 9.
    Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, et al. Infant infections and respiratory symptoms in relation to in utero arsenic exposure in a U.S. cohort. Environ Health Perspect. 2016;124(6):840–7.  https://doi.org/10.1289/ehp.1409282. PubMedGoogle Scholar
  10. 10.
    Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, Lantz RC, Gandolfi AJ, Gonzalez-De Alba C. In utero and early childhood exposure to arsenic decreases lung function in children. J Appl Toxicol. 2015;35(4):358–66.  https://doi.org/10.1002/jat.3023.PubMedCrossRefGoogle Scholar
  11. 11.
    Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, Steinmaus C. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect. 2012;120(11):1527–31.  https://doi.org/10.1289/ehp.1104867.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol. 2007;166(12):1381–91.  https://doi.org/10.1093/aje/kwm238.PubMedCrossRefGoogle Scholar
  13. 13.
    Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185(3):197–202.  https://doi.org/10.1016/j.toxlet.2009.01.001.PubMedCrossRefGoogle Scholar
  14. 14.
    von Ehrenstein OS, Poddar S, Yuan Y, Mazumder DG, Eskenazi B, Basu A, et al. Children’s intellectual function in relation to arsenic exposure. Epidemiology. 2007;18(1):44–51.  https://doi.org/10.1097/01.ede.0000248900.65613.a9.CrossRefGoogle Scholar
  15. 15.
    Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Karagas MR. Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect. 2012;120(10):1418–24.  https://doi.org/10.1289/ehp.1205014.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Jackson BP, Taylor VF, Karagas MR, Punshon T, Cottingham KL. Arsenic, organic foods, and brown rice syrup. Environ Health Perspect. 2012;120(5):623–6.  https://doi.org/10.1289/ehp.1104619.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Karagas MR, Punshon T, Sayarath V, Jackson BP, Folt CL, Cottingham KL. Association of rice and rice-product consumption with arsenic exposure early in life. JAMA Pediatr. 2016;170(6):609–16.  https://doi.org/10.1001/jamapediatrics.2016.0120.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    •• Quansah R, Armah FA, Essumang DK, Luginaah I, Clarke E, Marfoh K, et al. Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect. 2015;123(5):412–21.  https://doi.org/10.1289/ehp.1307894. Provides a concise systematic review of reproductive/birth outcomes and perinatal health associated with iAs exposure. PubMedPubMedCentralGoogle Scholar
  19. 19.
    El-Baz MAH, El-Deeb TS, El-Noweihi AM, Mohany KM, Shaaban OM, Abbas AM. Environmental factors and apoptotic indices in patients with intrauterine growth retardation: a nested case-control study. Environ Toxicol Pharmacol. 2015;39(2):589–96.  https://doi.org/10.1016/j.etap.2015.01.009.PubMedCrossRefGoogle Scholar
  20. 20.
    Peng S, Liu L, Zhang X, Heinrich J, Zhang J, Schramm KW, et al. A nested case-control study indicating heavy metal residues in meconium associate with maternal gestational diabetes mellitus risk. Environ Health. 2015;14(1):19.  https://doi.org/10.1186/s12940-015-0004-0.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect. 2000;108(7):667–73.  https://doi.org/10.1289/ehp.00108667.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Gelmann ER, Gurzau E, Gurzau A, Goessler W, Kunrath J, Yeckel CW, et al. A pilot study: the importance of inter-individual differences in inorganic arsenic metabolism for birth weight outcome. Environ Toxicol Pharmacol. 2013;36(3):1266–75.  https://doi.org/10.1016/j.etap.2013.10.006.PubMedCrossRefGoogle Scholar
  23. 23.
    Laine JE, Bailey KA, Rubio-Andrade M, Olshan AF, Smeester L, Drobna Z, et al. Maternal arsenic exposure, arsenic methylation efficiency, and birth outcomes in the Biomarkers of Exposure to ARsenic (BEAR) pregnancy cohort in Mexico. Environ Health Perspect. 2015;123(2):186–92.  https://doi.org/10.1289/ehp.1307476. PubMedGoogle Scholar
  24. 24.
    Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, et al. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol. 2009;169(3):304–12.  https://doi.org/10.1093/aje/kwn332. PubMedCrossRefGoogle Scholar
  25. 25.
    Gilbert-Diamond D, Emond JA, Baker ER, Korrick SA, Karagas MR. Relation between arsenic exposure and birth outcomes in a cohort of mothers and their newborns from New Hampshire. Environ Health Perspect. 2016;124(8):1299–307.  https://doi.org/10.1289/ehp.1510065.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Davis MA, Higgins J, Li Z, Gilbert-Diamond D, Baker ER, Das A, et al. Preliminary analysis of in utero low-level arsenic exposure and fetal growth using biometric measurements extracted from fetal ultrasound reports. Environ Health. 2015;14(1):1–11.  https://doi.org/10.1186/1476-069x-14-12. CrossRefGoogle Scholar
  27. 27.
    Newcombe R, Milne BJ, Caspi A, Poulton R, Moffitt TE. Birthweight predicts IQ: fact or artefact? Twin Res Hum Genet. 2007;10(4):581–6.  https://doi.org/10.1375/twin.10.4.581.PubMedCrossRefGoogle Scholar
  28. 28.
    Gale CR, O'Callaghan FJ, Bredow M, Martyn CN. The influence of head growth in fetal life, infancy, and childhood on intelligence at the ages of 4 and 8 years. Pediatrics. 2006;118(4):1486–92.  https://doi.org/10.1542/peds.2005-2629.PubMedCrossRefGoogle Scholar
  29. 29.
    Dakeishi M, Murata K, Grandjean P. Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ Health. 2006;5(1):31.  https://doi.org/10.1186/1476-069x-5-31.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Yorifuji T, Kato T, Ohta H, Bellinger DC, Matsuoka K, Grandjean P. Neurological and neuropsychological functions in adults with a history of developmental arsenic poisoning from contaminated milk powder. Neurotoxicol Teratol. 2016;53:75–80.  https://doi.org/10.1016/j.ntt.2015.12.001.PubMedCrossRefGoogle Scholar
  31. 31.
    Wasserman GA, Liu X, Parvez F, Factor-Litvak P, Ahsan H, Levy D, et al. Arsenic and manganese exposure and children’s intellectual function. Neurotoxicology. 2011;32(4):450–7.  https://doi.org/10.1016/j.neuro.2011.03.009.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, et al. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ Health Perspect. 2007;115(9):1371–5.  https://doi.org/10.1289/ehp.9961.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Hsieh RL, Huang YL, Shiue HS, Huang SR, Lin MI, Mu SC, et al. Arsenic methylation capacity and developmental delay in preschool children in Taiwan. Int J Hyg Environ Health. 2014;217(6):678–86.  https://doi.org/10.1016/j.ijheh.2014.02.004.PubMedCrossRefGoogle Scholar
  34. 34.
    Wasserman GA, Liu X, Loiacono NJ, Kline J, Factor-Litvak P, van Geen A, et al. A cross-sectional study of well water arsenic and child IQ in Maine schoolchildren. Environ Health. 2014;13(1):23.  https://doi.org/10.1186/1476-069x-13-23. PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Hamadani JD, Tofail F, Nermell B, Gardner R, Shiraji S, Bottai M, et al. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol. 2011;40(6):1593–604.  https://doi.org/10.1093/ije/dyr176.PubMedCrossRefGoogle Scholar
  36. 36.
    Hamadani JD, SM G-MG, Tofail F, Nermell B, Fangstrom B, Huda SN, et al. Pre- and postnatal arsenic exposure and child development at 18 months of age: a cohort study in rural Bangladesh. Int J Epidemiol. 2010;39(5):1206–16.  https://doi.org/10.1093/ije/dyp369. PubMedCrossRefGoogle Scholar
  37. 37.
    Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008;116(4):524–31.  https://doi.org/10.1289/ehp.10861.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, Banerjee A, et al. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol. 2008;27(5):381–6.  https://doi.org/10.1177/0960327108094607.PubMedCrossRefGoogle Scholar
  39. 39.
    Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: a review. Environ Health. 2013;12(1):73.  https://doi.org/10.1186/1476-069X-12-73. PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Smith AH, Yunus M, Khan AF, Ercumen A, Yuan Y, Smith MH, et al. Chronic respiratory symptoms in children following in utero and early life exposure to arsenic in drinking water in Bangladesh. Int J Epidemiol. 2013;42(4):1077–86.  https://doi.org/10.1093/ije/dyt120.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Rahman A, Vahter M, Ekstrom EC, Persson LA. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119(5):719–24.  https://doi.org/10.1289/ehp.1002265. PubMedCrossRefGoogle Scholar
  42. 42.
    Farzan SF, Korrick S, Li Z, Enelow R, Gandolfi AJ, Madan J, et al. In utero arsenic exposure and infant infection in a United States cohort: a prospective study. Environ Res. 2013;126:24–30.  https://doi.org/10.1016/j.envres.2013.05.001.PubMedCrossRefGoogle Scholar
  43. 43.
    Ahmed S, Akhtar E, Roy A, von Ehrenstein OS, Vahter M, Wagatsuma Y, et al. Arsenic exposure alters lung function and airway inflammation in children: a cohort study in rural Bangladesh. Environ Int. 2017;101:108–16.  https://doi.org/10.1016/j.envint.2017.01.014.PubMedCrossRefGoogle Scholar
  44. 44.
    Dauphine DC, Ferreccio C, Guntur S, Yuan Y, Hammond SK, Balmes J, et al. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health. 2011;84(6):591–600.  https://doi.org/10.1007/s00420-010-0591-6.PubMedCrossRefGoogle Scholar
  45. 45.
    Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, et al. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007;3(11):e207.  https://doi.org/10.1371/journal.pgen.0030207.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, et al. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environ Mol Mutagen. 2014;55(3):196–208.  https://doi.org/10.1002/em.21842.PubMedCrossRefGoogle Scholar
  47. 47.
    Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AM, et al. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci. 2012;129(2):305–14.  https://doi.org/10.1093/toxsci/kfs202.PubMedCrossRefGoogle Scholar
  48. 48.
    Soto-Pena GA, Luna AL, Acosta-Saavedra L, Conde P, Lopez-Carrillo L, Cebrian ME, et al. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 2006;20(6):779–81.  https://doi.org/10.1096/fj.05-4860fje.PubMedCrossRefGoogle Scholar
  49. 49.
    Ahmed S, Moore SE, Kippler M, Gardner R, Hawlader MD, Wagatsuma Y, et al. Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh. Toxicol Sci. 2014;141(1):166–75.  https://doi.org/10.1093/toxsci/kfu113.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Smeester L, Bommarito PA, Martin EM, Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, et al. Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response. Environ Toxicol Pharmacol. 2017;52:183–7.  https://doi.org/10.1016/j.etap.2017.04.007.PubMedCrossRefGoogle Scholar
  51. 51.
    Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 2011;342(may05 2):d2431.  https://doi.org/10.1136/bmj.d2431.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, et al. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med. 2013;159(10):649–59.  https://doi.org/10.7326/0003-4819-159-10-201311190-00719. PubMedPubMedCentralGoogle Scholar
  53. 53.
    Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between I schemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996;16(4):504–10.  https://doi.org/10.1161/01.ATV.16.4.504.PubMedCrossRefGoogle Scholar
  54. 54.
    Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 1999;33(1):74–8.  https://doi.org/10.1161/01.HYP.33.1.74.PubMedCrossRefGoogle Scholar
  55. 55.
    Rosenberg HG. Systemic arterial disease with myocardial infarction. Report on two infants. Circulation. 1973;47(2):270–5.  https://doi.org/10.1161/01.CIR.47.2.270.PubMedCrossRefGoogle Scholar
  56. 56.
    Systemic RHG. Arterial disease and chronic arsenicism in infants. Arch Pathol. 1974;97(6):360–5.Google Scholar
  57. 57.
    Rahman M, Sohel N, Yunus M, Chowdhury ME, Hore SK, Zaman K, et al. Increased childhood mortality and arsenic in drinking water in MATLAB, Bangladesh: a population-based cohort study. PLoS One. 2013;8(1):e55014.  https://doi.org/10.1371/journal.pone.0055014.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Hawkesworth S, Wagatsuma Y, Kippler M, Fulford AJ, Arifeen SE, Persson LA, et al. Early exposure to toxic metals has a limited effect on blood pressure or kidney function in later childhood, rural Bangladesh. Int J Epidemiol. 2013;42(1):176–85.  https://doi.org/10.1093/ije/dys215.PubMedCrossRefGoogle Scholar
  59. 59.
    Osorio-Yáñez C, Ayllon-Vergara JC, Aguilar-Madrid G, Arreola-Mendoza L, Hernández-Castellanos E, Barrera-Hernández A, et al. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic. Environ Health Perspect. 2013;121(9):1090–6.  https://doi.org/10.1289/ehp.1205994. PubMedPubMedCentralGoogle Scholar
  60. 60.
    Farzan SF, Brickley EB, Li Z, Gilbert-Diamond D, Gossai A, Chen Y, et al. Maternal and infant inflammatory markers in relation to prenatal arsenic exposure in a U.S. pregnancy cohort. Environ Res. 2017;156:426–33.  https://doi.org/10.1016/j.envres.2017.03.056.PubMedCrossRefGoogle Scholar
  61. 61.
    Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomark Prev. 2008;17(8):1982–7.  https://doi.org/10.1158/1055-9965.epi-07-2816.CrossRefGoogle Scholar
  62. 62.
    Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect. 2006;114(8):1293–6.  https://doi.org/10.1289/ehp.8832.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Wang JP, Qi L, Moore MR, Ng JC. A review of animal models for the study of arsenic carcinogenesis. Toxicol Lett. 2002;133(1):17–31.  https://doi.org/10.1016/S0378-4274(02)00086-3.PubMedCrossRefGoogle Scholar
  64. 64.
    Waalkes MP, Ward JM, Liu J, Diwan BA. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol. 2003;186(1):7–17.  https://doi.org/10.1016/S0041-008X(02)00022-4.PubMedCrossRefGoogle Scholar
  65. 65.
    Tokar EJ, Diwan BA, Ward JM, Delker DA, Waalkes MP. Carcinogenic effects of “whole-life” exposure to inorganic arsenic in CD1 mice. Toxicol Sci. 2011;119(1):73–83.  https://doi.org/10.1093/toxsci/kfq315.PubMedCrossRefGoogle Scholar
  66. 66.
    Waalkes MP, Ward JM, Diwan BA. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis. 2004;25(1):133–41.  https://doi.org/10.1093/carcin/bgg181. PubMedCrossRefGoogle Scholar
  67. 67.
    Liu J, Xie Y, Cooper R, Ducharme DM, Tennant R, Diwan BA, et al. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol. 2007;220(3):284–91.  https://doi.org/10.1016/j.taap.2007.01.018.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Tseng C-H. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health, Part C. 2007;25(1):1–22.  https://doi.org/10.1080/10590500701201695.CrossRefGoogle Scholar
  69. 69.
    Tokar EJ, Diwan BA, Thomas DJ, Waalkes MP. Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice. Arch Toxicol. 2012;86(6):975–82.  https://doi.org/10.1007/s00204-012-0820-8.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Waalkes MP, Qu W, Tokar EJ, Kissling GE, Dixon D. Lung tumors in mice induced by “whole-life” inorganic arsenic exposure at human-relevant doses. Arch Toxicol. 2014;88(8):1619–29.  https://doi.org/10.1007/s00204-014-1305-8.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Waalkes MP, Liu J, Diwan BA. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol. 2007;222(3):271–80.  https://doi.org/10.1016/j.taap.2006.12.034.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, et al. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology. 2007;236(1–2):7–15.  https://doi.org/10.1016/j.tox.2007.03.021.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Sullivan JP, Minna JD, Shay JW. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev. 2010;29(1):61–72.  https://doi.org/10.1007/s10555-010-9216-5.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea—a paradigm shift. Cancer Res. 2006;66(4):1883–90; discussion 95-6.  https://doi.org/10.1158/0008-5472.CAN-05-3153.PubMedCrossRefGoogle Scholar
  75. 75.
    Kangsamaksin T, Park HJ, Trempus CS, Morris RJ. A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol Carcinog. 2007;46(8):579–84.  https://doi.org/10.1002/mc.20355.PubMedCrossRefGoogle Scholar
  76. 76.
    Sun Y, Tokar EJ, Waalkes MP. Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic. Toxicol Sci: Off J Soc Toxicol. 2012;125(1):20–9.  https://doi.org/10.1093/toxsci/kfr282. CrossRefGoogle Scholar
  77. 77.
    Chang Q, Chen B, Thakur C, Lu Y, Chen F. Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61 cancer stem cells. Oncotarget. 2014;5(5):1290–303.  https://doi.org/10.18632/oncotarget.1789. PubMedCrossRefGoogle Scholar
  78. 78.
    Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ, et al. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 2008;68(20):8278–85.  https://doi.org/10.1158/0008-5472.can-08-2099.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, et al. Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis. PLoS One. 2012;7(6):e38713.  https://doi.org/10.1371/journal.pone.0038713.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Aung KH, Kyi-Tha-Thu C, Sano K, Nakamura K, Tanoue A, Nohara K, et al. Prenatal exposure to arsenic impairs behavioral flexibility and cortical structure in mice. Front Neurosci. 2016;10:137.  https://doi.org/10.3389/fnins.2016.00137. PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Gutierrez-Torres DS, Gonzalez-Horta C, Del Razo LM, Infante-Ramirez R, Ramos-Martinez E, Levario-Carrillo M, et al. Prenatal exposure to sodium Arsenite alters placental glucose 1, 3, and 4 transporters in BALB/c mice. Biomed Res Int. 2015;2015:175025.  https://doi.org/10.1155/2015/175025. PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    •• Rodriguez KF, Ungewitter EK, Crespo-Mejias Y, Liu C, Nicol B, Kissling GE, et al. Effects of in utero exposure to arsenic during the second half of gestation on reproductive end points and metabolic parameters in female CD-1 mice. Environ Health Perspect. 2016;124(3):336–43.  https://doi.org/10.1289/ehp.1509703. This study illustrates that even at the WHO recommended limit of 10ppb for arsenic in drinking water, prenatal iAs exposure is associated with late onset adverse outcomes. PubMedCrossRefGoogle Scholar
  83. 83.
    Lantz RC, Chau B, Sarihan P, Witten ML, Pivniouk VI, Chen GJ. In utero and postnatal exposure to arsenic alters pulmonary structure and function. Toxicol Appl Pharmacol. 2009;235(1):105–13.  https://doi.org/10.1016/j.taap.2008.11.012.PubMedCrossRefGoogle Scholar
  84. 84.
    Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou Y-S, et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst. 2004;96(6):466–74.  https://doi.org/10.1093/jnci/djh070.PubMedCrossRefGoogle Scholar
  85. 85.
    Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, et al. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect. 2011;119(2):258–64.  https://doi.org/10.1289/ehp.1002086. PubMedCrossRefGoogle Scholar
  86. 86.
    Bailey KA, Laine J, Rager JE, Sebastian E, Olshan A, Smeester L, et al. Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci: Off J Soc Toxicol. 2014;139(2):328–37.  https://doi.org/10.1093/toxsci/kfu053. CrossRefGoogle Scholar
  87. 87.
    Kile ML, Houseman EA, Baccarelli AA, Quamruzzaman Q, Rahman M, Mostofa G, et al. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014;9(5):774–82.  https://doi.org/10.4161/epi.28153.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Rojas D, Rager JE, Smeester L, Bailey KA, Drobná Z, Rubio-Andrade M, et al. Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015;143(1):97–106.  https://doi.org/10.1093/toxsci/kfu210.PubMedCrossRefGoogle Scholar
  89. 89.
    Sanders AP, Smeester L, Rojas D, DeBussycher T, Wu MC, Wright FA, et al. Cadmium exposure and the epigenome: exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs. Epigenetics. 2014;9(2):212–21.  https://doi.org/10.4161/epi.26798.PubMedCrossRefGoogle Scholar
  90. 90.
    Horikoshi M, Yaghootkar H, Mook-Kanamori DO, Sovio U, Taal HR, Hennig BJ, et al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet. 2013;45(1):76–82.  https://doi.org/10.1038/ng.2477.PubMedCrossRefGoogle Scholar
  91. 91.
    St-Pierre J, Hivert M-F, Perron P, Poirier P, Guay S-P, Brisson D, et al. IGF2 DNA methylation is a modulator of newborn’s fetal growth and development. Epigenetics. 2012;7(10):1125–32.  https://doi.org/10.4161/epi.21855.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    • Martin E, Smeester L, Bommarito PA, Grace MR, Boggess K, Kuban K, et al. Sexual epigenetic dimorphism in the human placenta: implications for susceptibility during the prenatal period. Epigenomics. 2017;9(3):267–78.  https://doi.org/10.2217/epi-2016-0132. This study highlights sexually-dimorphic epigenetic patterns in the placenta that likely influence the response to toxic substances such as inorganic arsenic. PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Silveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease (DOHaD). J pediatr. 2007;83(6):494–504.  https://doi.org/10.2223/JPED.1728.CrossRefGoogle Scholar
  94. 94.
    Vickers M. Early life nutrition, epigenetics and programming of later life disease. Nutrients. 2014;6(6):2165–78.  https://doi.org/10.3390/nu6062165.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Vanhees K, Vonhogen IG, van Schooten FJ, Godschalk RW. You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring. Cell Mol life Sci: CMLS. 2014;71(2):271–85.  https://doi.org/10.1007/s00018-013-1427-9. PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Lisa Smeester
    • 1
  • Rebecca C. Fry
    • 1
    • 2
  1. 1.Department of Environmental Sciences and Engineering, Gillings School of Global Public HealthUniversity of North CarolinaChapel HillUSA
  2. 2.Curriculum in Toxicology, School of MedicineUniversity of North CarolinaChapel HillUSA

Personalised recommendations